Second-quarter Sales of AstraZeneca's COVID-19 Vaccine More Than Tripled to $894 Million ... - Latest Tweet by Reuters
The latest Tweet by Reuters states, 'Second-quarter sales of AstraZeneca's COVID-19 vaccine more than tripled to $894 million from the first quarter, but the drugmaker again delayed its U.S. application for approval as it gathers more data for submissions ...'
(SocialLY brings you all the latest breaking news, fact checks and information from social media world, including Twitter (X), Instagram and Youtube. The above post contains publicly available embedded media, directly from the user's social media account and the views appearing in the social media post do not reflect the opinions of LatestLY.)